SEC CIK 1601695
Reed Willie M
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| ZTSview stock → | 12,864 | 2026-02-19 |
Position History — ZTS
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ZTS
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-02-19 | Option exercise (derivative) | 1,619.33 | — | 0 |
| 2026-02-19 | Option exercise | 1,619 | — | 12,864 |
| 2026-02-18 | Grant / award (derivative) | 1,936 | $0.00 | 1,936 |
| 2025-03-11 | Open-market sale | 1,210 | $166.14 | 11,245 |
| 2025-02-19 | Grant / award (derivative) | 1,596 | $0.00 | 1,596 |
| 2025-02-08 | Option exercise (derivative) | 1,225.4 | — | 0 |
| 2025-02-08 | Option exercise | 1,225 | — | 12,455 |
| 2025-02-06 | Option exercise (derivative) | 1,236.21 | — | 0 |
| 2025-02-06 | Option exercise | 1,236 | — | 11,230 |
| 2024-03-11 | Open-market sale | 1,370 | $182.68 | 9,994 |
| 2024-02-10 | Option exercise (derivative) | 1,463.39 | — | 1,212.31 |
| 2024-02-10 | Option exercise | 1,463 | — | 11,364 |
| 2024-02-08 | Option exercise (derivative) | 1,493.27 | — | 0 |
| 2024-02-08 | Option exercise | 1,493 | — | 9,901 |
| 2024-02-06 | Grant / award (derivative) | 1,223 | $0.00 | 1,223 |
| 2023-02-11 | Option exercise (derivative) | 1,626.84 | — | 2,651.93 |
| 2023-02-11 | Option exercise | 1,626 | — | 8,408 |
| 2023-02-08 | Grant / award (derivative) | 1,480 | $0.00 | 1,480 |
| 2022-06-10 | Open-market sale | 1,855 | $162.31 | 6,782 |
| 2022-02-12 | Option exercise (derivative) | 2,673.12 | — | 4,244.81 |
| 2022-02-12 | Option exercise | 2,673 | — | 8,637 |
| 2022-02-08 | Grant / award (derivative) | 1,192 | $0.00 | 6,917.94 |
| 2021-08-23 | Open-market sale | 1,450 | $207.10 | 5,964 |
| 2021-02-13 | Option exercise (derivative) | 2,779.15 | — | 5,694.57 |
| 2021-02-13 | Option exercise | 2,779 | — | 7,414 |
| 2021-02-10 | Grant / award (derivative) | 1,431 | $0.00 | 8,473.72 |
| 2020-08-13 | Open-market sale | 1,885 | $159.07 | 4,635 |
| 2020-02-14 | Option exercise (derivative) | 3,704.7 | — | 7,002.83 |
| 2020-02-14 | Option exercise | 3,704 | — | 6,520 |
| 2020-02-11 | Grant / award (derivative) | 1,596 | $0.00 | 10,707.53 |
| 2019-06-13 | Open-market sale | 1,900 | $110.58 | 2,816 |
| 2019-02-19 | Option exercise (derivative) | 4,150.39 | — | 9,058.37 |
| 2019-02-19 | Option exercise | 4,150 | — | 4,716 |
| 2019-02-12 | Grant / award (derivative) | 2,628 | $0.00 | 13,208.75 |
| 2018-11-30 | Open-market sale | 3,205 | $93.74 | 566 |
| 2018-02-27 | Option exercise (derivative) | 3,771.06 | — | 10,514.19 |
| 2018-02-27 | Option exercise | 3,771 | — | 3,771 |
| 2018-02-13 | Grant / award (derivative) | 2,730 | $73.24 | 14,285.25 |
| 2017-02-14 | Grant / award (derivative) | 3,635 | $55.02 | 11,476.6 |
| 2016-02-19 | Grant / award (derivative) | 4,064 | $41.83 | 7,779.94 |
| 2015-02-27 | Grant / award (derivative) | 3,688.44 | $46.09 | 3,688.44 |
| 2014-03-04 | Grant / award (derivative) | 4,532.21 | $30.89 | 4,532.21 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.